ENDRA Life Sciences
ENDRA Life Sciences Inc. (NASDAQ: NDRA) is a diagnostics/medical-device company headquartered in Ann Arbor, Michigan, developing TAEUS, a thermo-acoustic enhanced ultrasound platform that measures liver fat content at the point of care for steatotic liver disease (SLD/MASLD/MASH) monitoring; the company is pursuing a merger with Noble Africa (an ASP Isotopes affiliate) expected to close in Q4 2026.
Company Info
Sector:Diagnostics / Medical Devices
Headquarters:Ann Arbor, Michigan, USA
Founded:2007
Website:www.endrainc.com/
Upcoming Milestones & Key Dates
2026-12-31
Corporate
Targeted Noble Africa merger close (Q4 2026)
Clinical Development Pipeline
TAEUS Liver
Target: Thermo-acoustic enhanced ultrasoundRecent News
No recent news updates available for this company.
Leadership Team
Alexander Y. Tokman
CEO and Chairman
Richard Jacroux
CFO and Secretary
Dr. Jonathan Behr, PhD
Co-Founder